Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $51.4900 (-0.16%) ($51.4900 - $51.4900) on Mon. Jan. 23, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.43% (three month average) | RSI | 32 | Latest Price | $51.4900(-0.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.4% a day on average for past five trading days. | Weekly Trend | HALO declines -3.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(40%) XBI(39%) IFRA(38%) IWO(34%) IWM(33%) | Factors Impacting HALO price | HALO will decline at least -1.215% in a week (0% probabilities). VXX(-15%) VIXM(-11%) UUP(-11%) GLD(-11%) BND(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.215% (StdDev 2.43%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $43.63(-15.27%) | Resistance Level | $53.96 | 5 Day Moving Average | $51.59(-0.19%) | 10 Day Moving Average | $51.95(-0.89%) | 20 Day Moving Average | $53.96(-4.58%) | To recent high | -13.2% | To recent low | 12.5% | Market Cap | $7.037b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |